OHSU acquires BSD-500 Hyperthermia System

April 14, 2016

The Company ended the quarter with a total of $5.7 million of cash and investments.  On June 17, 2010, the Company secured a committed equity financing facility under which it may sell up to $15 million of common stock to Small Cap Biotech Value Ltd. over a 24 month period.

Recent Company Highlights

Celsion appointed Jeffrey W. Church as Chief Financial Officer.Patient enrollment for the Phase III Heat trial to date is over 67% complete.  Efforts to stimulate patient enrollment continue with full enrollment expected by the end of this year remain a priority for the Company.  ThermoDox? Abstract presented at the American Society of Clinical Oncology 2010 Annual Meeting.Celsion announced ThermoDox? Abstract accepted at the American Society for Radiation Oncology 2010 Annual Meeting.Celsion entered into a $15 Million Committed Equity Financing Facility with Small Cap Biotech Value, Ltd on terms favorable to traditional financing.

SOURCE Celsion Corporation